Hypotension News and Research

RSS
FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Investigational LCZ696 drug: A real breakthrough for patients with heart failure

Investigational LCZ696 drug: A real breakthrough for patients with heart failure

Study on patients with type 2 diabetes examines fracture risk with antihypertensive treatment

Study on patients with type 2 diabetes examines fracture risk with antihypertensive treatment

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Phase 3 ASPIRE clinical trial meets primary endpoint of progression-free survival

Kaleo announces U.S. availability of EVZIO for emergency treatment of opioid overdose

Kaleo announces U.S. availability of EVZIO for emergency treatment of opioid overdose

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

UCB, Dermira enter into licensing agreement for development, commercialization of Cimzia

Functional status informs blood pressure risks in elderly

Functional status informs blood pressure risks in elderly

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

BioDelivery Sciences receives approval of NDA for BUNAVAIL from FDA

Edge Therapeutics commences enrollment in second cohort of EG-1962 Phase 1/2 NEWTON study for aSAH

Edge Therapeutics commences enrollment in second cohort of EG-1962 Phase 1/2 NEWTON study for aSAH

Experts from ProfNet network available to discuss timely issues in coverage area

Experts from ProfNet network available to discuss timely issues in coverage area

Inotropic agents support epoprostenol initiation in severe PAH

Inotropic agents support epoprostenol initiation in severe PAH

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

FDA approves Bayer's Kogenate FS antihemophilic factor VIII to prevent bleeding episodes in adults with hemophilia A

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

Bristol-Myers Squibb to present new immunotherapy study data at ASCO Annual Meeting

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

Genmab/GSK receive FDA sBLA approval for Arzerra in combination with chlorambucil for treatment of CLL

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Clonidine increases hypotension and non-fatal cardiac arrest after noncardiac surgery

Clonidine increases hypotension and non-fatal cardiac arrest after noncardiac surgery

rEVO Biologics commences ATryn Phase 3 clinical program for treatment of preeclampsia in pregnant women

rEVO Biologics commences ATryn Phase 3 clinical program for treatment of preeclampsia in pregnant women

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

Study of astronauts show heart becomes more spherical when exposed to microgravity in space

Study of astronauts show heart becomes more spherical when exposed to microgravity in space